ELISA Kit for Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4)

SCCA2; PI11; SPB4; Leupin; Serpin Peptidase Inhibitor,Clade B,Member 4; Peptidase Inhibitor 11

Specificity

This assay has high sensitivity and excellent specificity for detection of Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4).
No significant cross-reactivity or interference between Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) and the recovery rates were calculated by comparing the measured value to the expected amount of Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-95 86
EDTA plasma(n=5) 97-105 102
heparin plasma(n=5) 83-90 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Serpin Peptidase Inhibitor,Clade B,Member 4 (SERPINB4) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-101% 86-99% 99-105% 92-99%
EDTA plasma(n=5) 93-101% 87-98% 79-96% 95-104%
heparin plasma(n=5) 96-105% 85-93% 78-98% 80-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Diseases of the Esophagus An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis PubMed: 19125792
Asian Journal of Oncology Role of squamous cell carcinoma antigen in monitoring of treatment response of cervical and vaginal malignancies www.asjo.in
25 Squamous cell carcinoma antigen reproducible marker and its clinicopathological correlation with preinvasive and invasive cervical cancer DOI: 10.4103/ccij.ccij_43_17
Head & neck Combination of serum squamous cell carcinoma antigens 1 and 2 as potential diagnostic marker for sinonasal squamous cell carcinoma and inverted papilloma Pubmed: 30376194
Journal of Cosmetic Dermatology Measurement of squamous cell carcinoma antigen 2 in lichen planus patients Pubmed: 31815365